New Role for Key Hearing Proteins May Explain Permanent Hearing Loss

Proteins that hearing scientists have long treated as the ear’s core sound-to-signal machinery appear to have a second, surprising job: helping control how fats are arranged in the outer membrane of cells.

New research from the National Institute on Deafness and Other Communication Disorders (NIDCD) suggests that when this membrane-control function is disrupted—by inherited mutations, acoustic stress, or ototoxic drugs—it may set off the chain of events that kills the inner ear’s sensory hair cells and leaves permanent hearing damage behind. The findings were presented at the Biophysical Society’s 70th Annual Meeting in San Francisco (Feb 21–25, 2026) and published in a subsequent news release.

The fragile cells that translate vibration into “neural code”

Hearing depends on specialized hair cells, which sit deep in the cochlea. Each hair cell carries a tuft of tiny projections, called stereocilia, organized in a bundle that moves in response to incoming sounds. When sound-driven motion deflects that bundle, it triggers a rapid electrical response inside the cell, launching signals that ultimately travel along the auditory nerve to the brain.

For years, a pair of proteins—TMC1 and TMC2—has been a central focus of hair cell research. They’re closely tied to the molecular process of mechanotransduction, where mechanical movement is converted into electrical activity. The clinical stakes are high: mutations in TMC1 are a well-established cause of inherited hearing loss, and defects in this system can lead to the loss of hair cells which do not naturally regenerate in humans.

A second role for TMC proteins: maintaining membrane “asymmetry”

In the new work, researchers led by Angela Ballesteros, PhD, report evidence that TMC1 and TMC2 do more than participate in ion flow. The team found that these proteins can also behave like lipid scramblases—molecular enzyme “mixers” that move phospholipids between the inner and outer layers of the cell membrane.

Healthy cell membranes are not symmetrical. Cells keep certain phospholipids preferentially on one side of the membrane, and disturbing that arrangement can act like an alarm bell. One phospholipid in particular—phosphatidylserine—is typically maintained on the inner layer. When it appears on the outside of the cell, it’s widely recognized as a biomarker of cellular distress and a common feature of programmed cell death pathways.

What goes wrong in hearing-loss mutations: Death signals on the surface

The NIDCD team reports that in mouse models carrying hearing-loss–associated TMC1 mutations, hair cells show signs of membrane breakdown consistent with abnormal scrambling. In their description, phosphatidylserine becomes exposed on the outer surface, and the membrane begins to lose its integrity—changes associated with apoptotic (cell death) processes.

“Hair cells from mouse models carrying mutations in TMC1 that cause hearing loss exhibit this membrane dysregulation—phosphatidylserine gets externalized, and the membrane starts blebbing and falling apart,” says Ballesteros. “This is an apoptotic hallmark. It's what's killing the hair cells.”

The researchers argue that this membrane-regulating function—rather than the better-known “channel” role—may be the critical trigger that pushes vulnerable hair cells toward death when TMC function is disrupted.

Why some antibiotics damage hearing: A link to scramblase activation

The same mechanism may also help explain drug-induced ototoxicity, particularly with aminoglycoside antibiotics, which have long been associated with hearing damage in some patients. The investigators report that these drugs can activate the membrane-disrupting scrambling activity in living systems, potentially collapsing the membrane’s normal lipid organization. That interpretation differs from earlier assumptions that aminoglycosides primarily harm hearing by interfering with TMC ion-channel behavior.

“Scientists initially thought these drugs caused hearing loss by blocking the channel function of TMCs in vivo,” said Hubert Lee, a postdoctoral fellow in Ballesteros’ lab. “But what we’re seeing now is that in the chaotic environment of the living hair cell, these drugs act as potent disruptors, triggering a collapse of membrane asymmetry. Yet, in the serene isolation of our reconstituted system, the protein remains indifferent to them, suggesting that other factors, such as lipid specificity or missing protein partners, are at play.”

The team also notes an important experimental nuance: drug effects observed in living hair cells may not always appear in simplified, reconstituted lab systems—hinting that additional factors such as lipid composition or missing proteins could shape how strongly aminoglycosides destabilize membranes in the real cochlear environment.

Cholesterol as a potential “dial” for risk—and a possible route to protection

One more finding could have practical implications: the researchers observed that scramblase activity varies with membrane cholesterol levels. If cholesterol content influences how readily this pathway activates, it raises the possibility—still speculative at this stage—that future protective strategies might involve modifying membrane conditions to reduce vulnerability to ototoxic drugs or to certain genetic forms of hearing loss.

“If we understand the mechanism by which these drugs activate the scramblase, we might be able to design new drugs that lack this effect,” says Yein Christina Park, graduate student at the NIH-JHU program and co-first author of this work. “We could potentially have antibiotics that don’t cause permanent hearing loss.”

Note: These results were presented at a scientific meeting and may evolve as additional data are published and peer-reviewed. Also see preprint: TMC1 and TMC2 are cholesterol-dependent scramblases that regulate membrane homeostasis in auditory hair cells.